Antibody-drug conjugate (ADC) combination therapy Clinical Trials

1 actively recruiting trial

Also known as: ADC + TKI/ICB + Cellular Therapy DS-8201, ADC + TKI/ICB + Cellular Therapy SG, ADC + TKI/ICB + Cellular Therapy T-DM1

Top Sponsors

Guangzhou Institute of Respiratory Disease1

Indications

HER2 Positive OR TROP2 Positive Non-Small Cell Lung Cancer1
Lung Cancer1
Cancer1

Other1 trial

Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.